Mycoplasma hominis as an Infectious Agent of the Human Prostate Carcinoma Cell Line LNCaP

M A Galyamina1, O V Pobeguts2, M E Bogomiakova2

  • 1Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical-Biological Agency of Russia, Moscow, Russia. mrogova@gmail.com.

Insights

Mycoplasma hominis (MHO) infection of prostate cancer cells shows MHO adapts by altering metabolism and membrane proteins. This provides insight into mycoplasma

Area of Science:

  • Microbiology
  • Oncology
  • Cell Biology

Background:

  • Mycoplasmas have been linked to cancer development, but the mechanisms are unclear.
  • Prostate cancer is a significant area of concern for neoplasm development.

Purpose of the Study:

  • To investigate the interaction between Mycoplasma hominis (MHO) and LNCaP prostate cancer cells.
  • To elucidate the adaptive mechanisms of MHO within a host cancer cell environment.

Main Methods:

  • Development of an infectious model using LNCaP cells and MHO.
  • Proteomic analysis to study MHO's functional changes during infection.
  • Observation of MHO's attachment, invasion, and metabolic shifts.

Main Results:

  • MHO successfully infected LNCaP cells without altering cell growth or morphology.
  • MHO underwent significant functional restructuring, including metabolic shifts to nucleoside utilization.
  • MHO adapted by altering membrane proteins and variable antigens for survival.

Conclusions:

  • MHO exhibits adaptive strategies for survival within prostate cancer cells.
  • Understanding these adaptations may reveal mechanisms of mycoplasma-induced oncogenesis.
  • The transcription factor YebC is hypothesized to be involved in MHO survival.